|80.85||+0.0600||+0.07%||Vol 1.99M||1Y Perf 2.80%|
|Sep 24th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||94.33||Analyst Rating||Moderate Buy 1.60|
|Potential %||16.67||Finscreener Ranking||★+ 44.64|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 46.12|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 52.42|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★+ 42.97|
|Price Range Ratio 52W %||50.86||Earnings Rating||Buy|
|Market Cap||40.42B||Earnings Date||4th Nov 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th Nov 2021|
|Estimated EPS Next Report||0.94|
|EPS Growth Next 5 Years %||10.00|
|Avg. Weekly Volume||2.27M|
|Avg. Monthly Volume||3.98M|
|Avg. Quarterly Volume||3.33M|
Baxter International Inc. (NYSE: BAX) stock closed at 80.85 per share at the end of the most recent trading day (a 0.07% change compared to the prior day closing price) with a volume of 2.01M shares and market capitalization of 40.42B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 50000 people. Baxter International Inc. CEO is Jose E. Almeida.
The one-year performance of Baxter International Inc. stock is 2.8%, while year-to-date (YTD) performance is 0.76%. BAX stock has a five-year performance of 70.25%. Its 52-week range is between 73.12 and 88.32, which gives BAX stock a 52-week price range ratio of 50.86%
Baxter International Inc. currently has a PE ratio of 38.40, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 3.37, a price to cashflow ratio of 20.70, a PEG ratio of 2.32, a ROA of 5.57%, a ROC of 8.23% and a ROE of 13.12%. The company’s profit margin is 9.26%, its EBITDA margin is 19.60%, and its revenue ttm is $12.20 Billion , which makes it $24.40 revenue per share.
Of the last four earnings reports from Baxter International Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.94 for the next earnings report. Baxter International Inc.’s next earnings report date is 04th Nov 2021.
The consensus rating of Wall Street analysts for Baxter International Inc. is Moderate Buy (1.6), with a target price of $94.33, which is +16.67% compared to the current price. The earnings rating for Baxter International Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Baxter International Inc. has a dividend yield of 1.36% with a dividend per share of $1.12 and a payout ratio of 47.00%.
Baxter International Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 6.18, ATR14 : 1.43, CCI20 : 0.83, Chaikin Money Flow : 0.10, MACD : 1.11, Money Flow Index : 54.65, ROC : -2.31, RSI : 53.55, STOCH (14,3) : 13.54, STOCH RSI : 0.02, UO : 38.29, Williams %R : -86.46), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Baxter International Inc. in the last 12-months were: Albert P L Stroucken (Option Excercise at a value of $155 987), Albert P L Stroucken (Sold 4 990 shares of value $421 954 ), Andrew Frye (Sold 10 999 shares of value $932 605 ), Peter S. Hellman (Option Excercise at a value of $155 987), Peter S. Hellman (Sold 4 990 shares of value $421 954 ), Sean B.W. Martin (Option Excercise at a value of $1 005 246), Sean B.W. Martin (Sold 19 800 shares of value $1 529 748 )
Thu, 02 Sep 2021 13:28 GMT Baxter to Snap Up Hill-Rom for $10.5B Shares Rise Pre-Market- TipRanks. All rights reserved.
Mon, 30 Aug 2021 11:56 GMT Will Hill-Rom Accept Baxters Offer Price of $150- TipRanks. All rights reserved.
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.